Weight Watchers Q2 revenue $162.3M, clinical subscribers up 55.7% YoY; reaffirms FY guidance

WW INTERNATIONAL, INC.

Q2 revenue $162.3M (down 14% YoY); clinical subscription revenue $39.9M, up 30.4% YoY.
End-of-period clinical subscribers 197K (+55.7% YoY); Core+ subscribers 541K (+13.9% YoY), third consecutive sequential growth.
Q2 net income $14.1M; Adjusted EBITDA $39.8M; operating cash flow $24.3M.
Reduced term loan principal by $41.4M via $36.8M cash prepayment; cash balance $101.5M.
Reaffirms FY2026 guidance: revenue $620-635M, Adjusted EBITDA $105-115M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.